SEC Form 4 · accession 0001209191-17-065220
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard E. Russell
Officer — President
Period of report
Dec 11, 2017
Accepted (ET)
Dec 12, 2017 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2017 | A | 40,000 | $0.00 | A | 40,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock option (Right to Buy)F2 | $6.05 | Dec 11, 2017 | A | 775,000 | A | — | Dec 10, 2027 | Common Stock | 775,000 | 775,000 | D |
Explanation of responses
- F1Represents shares of the Issuer's Common Stock underlying a time-based restricted stock unit award ("RSU"). The shares subject to this RSU will vest in four (4) equal annual installments commencing on the one-year anniversary of December 11, 2017, provided the Reporting Person has provided continuous service to the Issuer through the vesting date.
- F2This option vested as to 25% of the shares on December 11, 2018 and then in quarterly installments over 3 years thereafter.